Physiologically active erbstatin analogue compounds and compositions
    1.
    发明授权
    Physiologically active erbstatin analogue compounds and compositions 失效
    生理活性的erbstatin类似物和组合物

    公开(公告)号:US4925877A

    公开(公告)日:1990-05-15

    申请号:US17108

    申请日:1987-02-20

    CPC分类号: C07C251/00

    摘要: The present invention provides new physiological active substance erbstatin analogue compounds of a general formula (I), which have excellent tyrosine-specific protein-kinase inhibitory activity, antitumor activity and antimicrobial activity. ##STR1## (in which R.sup.1 represents a hydrogen atom, a lower alkanoyl group or a lower alkyl group; n represents a positive integer of 1 to 3;X represents a hydrogen atom or a halogen atom;Y represents a group of formula --CH.dbd.CH--NC, --CH.dbd.CH--NHR.sup.2 or --CH.sub.2 --CH.sub.2 --NHR.sup.2(where R.sup.2 represents a formyl group or a lower alkanoyl group; with the exception of the cases where X is hydrogen atom, (R.sup.1 O).sub.n group is 2,5-dihydroxy group and Y is --CH.dbd.CH--NHCHO or --CH.sub.2 --CH.sub.2 --NHCHO).The present invention further provides a tyrosine-specific protein-kinase inhibitor, tumoricide or bactericide containing at least one compound of the said formula (I).

    摘要翻译: 本发明提供了具有优异的酪氨酸特异性蛋白激酶抑制活性,抗肿瘤活性和抗菌活性的通式(I)的新的生理活性物质抑制剂类似物化合物。 (I)(其中R 1表示氢原子,低级烷酰基或低级烷基; n表示1〜3的正整数; X表示氢原子或卤素原子; Y表示 式-CH = CH-NC,-CH = CH-NHR 2或-CH 2 -CH 2 -NH 2(其中R 2表示甲酰基或低级烷酰基;除了X是氢原子,(R 1 O)n 基团是2,5-二羟基,Y是-CH = CH-NHCHO或-CH 2 -CH 2 -NHCHO),本发明还提供一种酪氨酸特异性蛋白激酶抑制剂,杀伤剂或杀菌剂,其含有至少一种化合物 所述式(I)。

    Treatment of elevated histamine and uric acid levels
    9.
    发明授权
    Treatment of elevated histamine and uric acid levels 失效
    治疗组胺升高和尿酸水平升高

    公开(公告)号:US4024253A

    公开(公告)日:1977-05-17

    申请号:US674009

    申请日:1976-04-05

    CPC分类号: A61K31/235 A61K31/60

    摘要: Compounds having the general formula ##STR1## (the meanings of R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are indicated hereinafter) and the pharmaceutically acceptable salts and esters thereof exhibit strong activities in inhibiting histidine decarboxylase and xanthine oxidase and are useful for treating elevated histamine and uric acid levels. One example is the compound of the formula ##STR2##

    摘要翻译: 具有通式的化合物(R1,R2,R3,R4和R5的含义如下所述),其药学上可接受的盐和酯在抑制组氨酸脱羧酶和黄嘌呤氧化酶中表现出强的活性,并且可用于治疗升高的组胺 和尿酸水平。 一个例子是式“IMAGE”的化合物

    Antibiotics aclacinomycins A and B
    10.
    发明授权
    Antibiotics aclacinomycins A and B 失效
    抗生素阿卡霉素A和B

    公开(公告)号:US3988315A

    公开(公告)日:1976-10-26

    申请号:US596682

    申请日:1975-07-16

    CPC分类号: C07H15/252 Y10S435/886

    摘要: New antitumor agents named aclacinomycins A and B, which are anthracycline glycosides and inhibit the growth of various microorganisms e.g., Staphylococcus aureus, Micrococcus flavus, Corynebacterium bovis and inhibit the growth of animal tumors such as leukemia L1210 and P388 and lymphoma 6C3HED in mice and hepatomas in rats are produced by the fermentation of a microorganism belonging to the genus Streptomyces which has been designated Streptomyces galilaeus (MA144-M1 and A.T.C.C. 31133); they are recovered from the broth by conventional methods for recovering antibiotics.

    摘要翻译: 新型抗肿瘤剂名为阿沙利霉素A和B,它们是蒽环类苷并抑制各种微生物的生长,例如金黄色葡萄球菌,黄曲霉,牛磺酸棒状杆菌,并抑制小鼠和肝癌中白血病L1210和P388和淋巴瘤6C3HED等动物肿瘤的生长 在大鼠中通过发酵属于链霉菌属(Streptomyces)的微生物来产生,其被命名为马链霉菌(Streptomyces galilaeus)(MA144-M1和ATCC 31133); 它们通过用于回收抗生素的常规方法从肉汤中回收。